SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Prestige Consumer Healthcare Inc. – ‘10-K’ for 3/31/16 – ‘EX-4.6’

On:  Tuesday, 5/17/16, at 8:37am ET   ·   For:  3/31/16   ·   Accession #:  1295947-16-51   ·   File #:  1-32433

Previous ‘10-K’:  ‘10-K’ on 5/14/15 for 3/31/15   ·   Next:  ‘10-K’ on 5/17/17 for 3/31/17   ·   Latest:  ‘10-K’ on 5/5/23 for 3/31/23   ·   1 Reference:  By:  Prestige Consumer Healthcare Inc. – ‘10-K’ on 5/7/21 for 3/31/21

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 5/17/16  Prestige Consumer Healthcare Inc. 10-K        3/31/16  120:25M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.96M 
 2: EX-4.6      Instrument Defining the Rights of Security Holders  HTML     43K 
 3: EX-10.23    Material Contract                                   HTML     90K 
 4: EX-10.34    Material Contract                                   HTML     42K 
 5: EX-10.35    Material Contract                                   HTML     68K 
 6: EX-21.1     Subsidiaries List                                   HTML     34K 
 7: EX-23.1     Consent of Experts or Counsel                       HTML     31K 
 8: EX-31.1     Certification -- §302 - SOA'02                      HTML     40K 
 9: EX-31.2     Certification -- §302 - SOA'02                      HTML     40K 
10: EX-32.1     Certification -- §906 - SOA'02                      HTML     33K 
11: EX-32.2     Certification -- §906 - SOA'02                      HTML     33K 
18: R1          Document and Entity Information                     HTML     59K 
19: R2          Consolidated Statements of Income and               HTML    120K 
                Comprehensive Income                                             
20: R3          Consolidated Balance Sheets                         HTML    119K 
21: R4          Consolidated Balance Sheets (Parentheticals)        HTML     49K 
22: R5          Consolidated Statements of Changes in               HTML    108K 
                Stockholders' Equity and Comprehensive Income                    
23: R6          Consolidated Statements of Cash Flows               HTML    169K 
24: R7          Business and Basis of Presentation                  HTML     81K 
25: R8          Acquisitions                                        HTML    121K 
26: R9          Accounts Receivable                                 HTML     46K 
27: R10         Inventories                                         HTML     42K 
28: R11         Property and Equipment                              HTML     48K 
29: R12         Goodwill                                            HTML    118K 
30: R13         Intangible Assets                                   HTML    239K 
31: R14         Other Accrued Liabilities                           HTML     50K 
32: R15         Long-Term Debt                                      HTML    102K 
33: R16         Fair Value Measurements                             HTML     59K 
34: R17         Stockholders' Equity                                HTML     42K 
35: R18         Earnings Per Share                                  HTML     62K 
36: R19         Share-Based Compensation                            HTML    149K 
37: R20         Accumulated Other Comprehensive Income (Loss)       HTML     41K 
38: R21         Income Taxes                                        HTML    151K 
39: R22         Commitments and Contingencies                       HTML     69K 
40: R23         Concentrations of Risk                              HTML     40K 
41: R24         Business Segments                                   HTML    310K 
42: R25         Unaudited Quarterly Financial Information           HTML    206K 
43: R26         Condensed Consolidating Financial Statements        HTML   1.31M 
44: R27         Subsequent Events                                   HTML     35K 
45: R28         Schedule II Valuation and Qualifying Accounts       HTML     89K 
46: R29         Business and Basis of Presentation (Policies)       HTML    129K 
47: R30         Business and Basis of Presentation (Tables)         HTML     50K 
48: R31         Acquisitions (Tables)                               HTML    103K 
49: R32         Accounts Receivable (Tables)                        HTML     43K 
50: R33         Inventories (Tables)                                HTML     42K 
51: R34         Property and Equipment (Tables)                     HTML     50K 
52: R35         Goodwill (Tables)                                   HTML    110K 
53: R36         Intangible Assets (Tables)                          HTML    222K 
54: R37         Other Accrued Liabilities (Tables)                  HTML     49K 
55: R38         Long-Term Debt Long-Term Debt (Tables)              HTML     65K 
56: R39         Fair Value Measurements (Tables)                    HTML     52K 
57: R40         Earnings Per Share (Tables)                         HTML     59K 
58: R41         Share-Based Compensation (Tables)                   HTML    128K 
59: R42         Accumulated Other Comprehensive Income (Loss)       HTML     40K 
                (Tables)                                                         
60: R43         Income Taxes (Tables)                               HTML    155K 
61: R44         Commitments and Contingencies (Tables)              HTML     67K 
62: R45         Business Segments (Tables)                          HTML    285K 
63: R46         Unaudited Quarterly Financial Information (Tables)  HTML    205K 
64: R47         Condensed Consolidating Financial Statements        HTML   1.30M 
                (Tables)                                                         
65: R48         Business and Basis of Presentation (Details)        HTML     32K 
66: R49         Business and Basis of Presentation (Property and    HTML     38K 
                Equipment) (Details)                                             
67: R50         Business and Basis of Presentation (Intangible      HTML     36K 
                Assets) (Details)                                                
68: R51         Business and Basis of Presentation (Cost of Sales)  HTML     36K 
                (Details)                                                        
69: R52         Business and Basis of Presentation (Recently        HTML     38K 
                Issued Accounting Standards) (Details)                           
70: R53         Acquisitions (Narrative) (Details)                  HTML    101K 
71: R54         Acquisitions (Allocations) (Details)                HTML    105K 
72: R55         Acquisitions (Pro Forma) (Details)                  HTML     43K 
73: R56         Accounts Receivable (Details)                       HTML     43K 
74: R57         Inventories (Details)                               HTML     43K 
75: R58         Property and Equipment (Details)                    HTML     52K 
76: R59         Goodwill (Details)                                  HTML     62K 
77: R60         Goodwill (Narrative) (Details)                      HTML     71K 
78: R61         Intangible Assets (Details)                         HTML    122K 
79: R62         Intangible Assets (Narrative) (Details)             HTML    148K 
80: R63         Intangible Assets (Expected Amortization Expense)   HTML     47K 
                (Details)                                                        
81: R64         Other Accrued Liabilities (Details)                 HTML     60K 
82: R65         Long-Term Debt (Narrative 2012 Senior Notes)        HTML     44K 
                (Details)                                                        
83: R66         Long-Term Debt (Narrative 2012 Term Loan and 2012   HTML    174K 
                ABL Revolver) (Details)                                          
84: R67         Long-Term Debt (Narrative 2013 Senior Notes)        HTML     40K 
                (Details)                                                        
85: R68         Long-Term Debt (Narrative 2016 Bridge Term Loans)   HTML     55K 
                (Details)                                                        
86: R69         Long-Term Debt (Narrative 2016 Senior Notes)        HTML     40K 
                (Details)                                                        
87: R70         Long-Term Debt (Narrative Redemptions and           HTML     78K 
                Restrictions) (Details)                                          
88: R71         Long-Term Debt (Schedule of Long-term Debt)         HTML     77K 
                (Details)                                                        
89: R72         Long-Term Debt (Maturities of Long-term Debt)       HTML     51K 
                (Details)                                                        
90: R73         Fair Value Measurements (Details)                   HTML     59K 
91: R74         Stockholders' Equity (Details)                      HTML     54K 
92: R75         Earnings Per Share (Details)                        HTML     59K 
93: R76         Earnings Per Share (Antidilutive Securities)        HTML     37K 
                (Details)                                                        
94: R77         Share-Based Compensation (Narrative) (Details)      HTML    165K 
95: R78         Share-Based Compensation (Restricted Shares         HTML     61K 
                Activity) (Details)                                              
96: R79         Share-Based Compensation (Stock Option Valuation    HTML     43K 
                Assumptions) (Details)                                           
97: R80         Share-Based Compensation (Stock Option Activity)    HTML     72K 
                (Details)                                                        
98: R81         Accumulated Other Comprehensive Income (Loss)       HTML     41K 
                (Components of AOCI) (Details)                                   
99: R82         Income Taxes (Narrative) (Details)                  HTML     54K 
100: R83         Income Taxes (Income Before Continuing Operations)  HTML     43K  
                (Details)                                                        
101: R84         Income Taxes (Components of Provision for Income    HTML     59K  
                Taxes) (Details)                                                 
102: R85         Income Taxes (Components of Deferred Tax Balances)  HTML     67K  
                (Details)                                                        
103: R86         Income Taxes (Reconciliation of Effective Tax       HTML     78K  
                Rate) (Details)                                                  
104: R87         Income Taxes (Uncertain Tax Liability Activity)     HTML     39K  
                (Details)                                                        
105: R88         Commitments and Contingencies (Future Minimum       HTML     63K  
                Rental Payments) (Details)                                       
106: R89         Commitments and Contingencies (Long-term Supply     HTML     47K  
                Agreement) (Details)                                             
107: R90         Concentrations of Risk (Details)                    HTML     58K  
108: R91         Business Segments (Information on Operating and     HTML    108K  
                Reportable Segments) (Details)                                   
109: R92         Business Segments (Revenue by Product) (Details)    HTML    127K  
110: R93         Business Segments (Narrative) (Details)             HTML     46K  
111: R94         Business Segments (Assets by Segment) (Details)     HTML     56K  
112: R95         Unaudited Quarterly Financial Information           HTML    107K  
                (Details)                                                        
113: R96         Condensed Consolidating Financial Statements        HTML    201K  
                (Condensed Consolidating Statements of Income and                
                Comprehensive Income) (Details)                                  
114: R97         Condensed Consolidating Financial Statements        HTML    199K  
                (Condensed Consolidating Balance Sheet) (Details)                
115: R98         Condensed Consolidating Financial Statements        HTML    448K  
                (Condensed Consolidating Statement of Cash Flows)                
                (Details)                                                        
116: R99         Subsequent Events (Details)                         HTML     62K  
117: R100        Schedule II Valuation and Qualifying Accounts       HTML     55K  
                (Details)                                                        
119: XML         IDEA XML File -- Filing Summary                      XML    207K  
118: EXCEL       IDEA Workbook of Financial Reports                  XLSX    169K  
12: EX-101.INS  XBRL Instance -- pbh-20160331                        XML   9.10M 
14: EX-101.CAL  XBRL Calculations -- pbh-20160331_cal                XML    330K 
15: EX-101.DEF  XBRL Definitions -- pbh-20160331_def                 XML   1.36M 
16: EX-101.LAB  XBRL Labels -- pbh-20160331_lab                      XML   2.47M 
17: EX-101.PRE  XBRL Presentations -- pbh-20160331_pre               XML   1.73M 
13: EX-101.SCH  XBRL Schema -- pbh-20160331                          XSD    247K 
120: ZIP         XBRL Zipped Folder -- 0001295947-16-000051-xbrl      Zip    497K  


‘EX-4.6’   —   Instrument Defining the Rights of Security Holders


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  SEC Exhibit  
Exhibit 4.6

FIRST SUPPLEMENTAL INDENTURE
Supplemental Indenture (this “Supplemental Indenture”), dated as of April 4, 2016, among DenTek Holdings, Inc., a Delaware corporation, DenTek Oral Care, Inc., a Tennessee corporation (each, a “Guaranteeing Subsidiary”), each a subsidiary of Prestige Brands, Inc., a Delaware corporation (the “Issuer”), and U.S. Bank National Association, a national banking association, as trustee (the “Trustee”).
W I T N E S S E T H
WHEREAS, the Issuer has heretofore executed and delivered to the Trustee an Indenture (the “Indenture”), dated as of February 19, 2016, providing for the issuance of an unlimited aggregate principal amount of 6.375% Senior Notes due 2024 (the “Notes”);
WHEREAS, the Indenture provides that under certain circumstances the Guaranteeing Subsidiary shall execute and deliver to the Trustee a supplemental indenture pursuant to which the Guaranteeing Subsidiary shall unconditionally guarantee all of the Issuer’s Obligations under the Notes and the Indenture on the terms and conditions set forth herein and under the Indenture (the “Guarantee”); and
WHEREAS, pursuant to Section 9.01 of the Indenture, the Trustee is authorized to execute and deliver this Supplemental Indenture.
NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Holders as follows:
(1)    Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture.
(2)    Agreement to Guarantee. The Guaranteeing Subsidiary acknowledges that it has received and reviewed a copy of the Indenture and all other documents it deems necessary to review in order to enter into this Supplemental Indenture, and acknowledges and agrees to (i) join and become a party to the Indenture as indicated by its signature below; (ii) be bound by the Indenture, as of the date hereof, as if made by, and with respect to, each signatory hereto; and (iii) perform all obligations and duties required of a Guarantor pursuant to the Indenture. The Guaranteeing Subsidiary hereby agrees to provide an unconditional Guarantee on the terms and subject to the conditions set forth in the Indenture, including, but not limited to, Article 10 thereof.
(3)    Execution and Delivery. The Guaranteeing Subsidiary agrees that the Guarantee shall remain in full force and effect notwithstanding the absence of the endorsement of any notation of such Guarantee on the Notes.
(4)    No Recourse Against Others. No past, present or future director, officer, employee, incorporator, member, partner or stockholder of the Issuer or any Guaranteeing Subsidiary (other than the Issuer and the Guarantors) shall have any liability for any obligations of the Issuer or the Guarantors (including the Guaranteeing Subsidiary) under the Notes, any Guarantees, the Indenture or this Supplemental Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. Each Holder by accepting Notes waives and releases all such liability. The waiver and release are part of the consideration for issuance of the Notes.

1


(5)    Governing Law. THIS SUPPLEMENTAL INDENTURE, AND THE RIGHTS AND DUTIES OF THE PARTIES HEREUNDER, WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK.
(6)    Counterparts. The parties may sign any number of copies of this Supplemental Indenture. Each signed copy shall be an original, but all of them together represent the same agreement. This Supplemental Indenture may be executed in multiple counterparts which, when taken together, shall constitute one instrument. The exchange of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmissions shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes.
(7)    Effect of Headings. The Section headings herein are for convenience only and shall not affect the construction hereof.
(8)    The Trustee. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Guaranteeing Subsidiary.
(9)    Benefits Acknowledged. The Guaranteeing Subsidiary’s Guarantee is subject to the terms and conditions set forth in the Indenture. The Guaranteeing Subsidiary acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated by the Indenture and this Supplemental Indenture and that the guarantee and waivers made by it pursuant to this Guarantee are knowingly made in contemplation of such benefits.
(10)    Successors. All agreements of the Guaranteeing Subsidiary in this Supplemental Indenture shall bind its Successors, except as otherwise provided in this Supplemental Indenture. All agreements of the Trustee in this Supplemental Indenture shall bind its successors.


2

Exhibit 4.6

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the date first above written.
DENTEK HOLDINGS, INC.
By:
    /s/ David S. Marberger    
Name: David S. Marberger
Title: Vice President and Treasurer
DENTEK ORAL CARE, INC.
By:
    /s/ David S. Marberger    
Name: David S. Marberger
Title: Vice President and Treasurer
U.S. BANK NATIONAL ASSOCIATION, as Trustee
By:
    /s/ Raymond S. Haverstock    
Name: Raymond S. Haverstock
Title: Vice President



Signature Page to First Supplemental Indenture (2024 Notes)

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:5/17/16
4/4/16
For Period end:3/31/16
2/19/168-K
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/07/21  Prestige Consumer Healthcare Inc. 10-K        3/31/21  133:15M
Top
Filing Submission 0001295947-16-000051   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 3, 8:00:23.2pm ET